Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/841 |
Resumo: | Introduction: Venous thromboembolism is a potentially fatal condition and frequent in oncologic patients. Quite often full anticoagulation is unfeasible, and placement of an inferior vena cava (IVC) filter becomes an option. Clinical indication, however, is controversial and expensive. Objective: To describe the demographic, clinical and epidemiological characteristics of oncologic patients submitted to IVC filter placement and their impact on global survival. Method: Retrospective cohort study with patients undergoing cancer treatment at INCA submitted to IVC filter placement from January 2015 to April 2017. Time between cancer diagnoses and death from any cause was considered for the analysis of the global 5-years survival. Descriptive analysis, survival estimates (Kaplan-Meyer) and Cox regression were performed. Results: 74 patients with a mean age of 54 (+15) years were included. Most of them had gynecological (52.7%) and digestive (20.3%) tumors. The median time between cancer diagnosis and IVC filter placement was 3.48 months (0-203). In the follow-up, 40 deaths (54.1%) were observed with a median time of 25 months (95% CI; 1.76 to 47.32). In the adjusted analysis, 5.63 times greater risk of death was verified in patients with IVC filter placement within six months after cancer diagnosis (HR=4.99; 95% CI; 2.20-11.33; p<0.001), and 2.47 times greater risk among those who did not do it at pre-operation (HR=2.47; 95% CI; 1.08-5.66; p=0.032). Conclusion: IVC filter placement was performed more frequently in patients with gynecological tumors and in until six months after cancer diagnosis was associated with increased risk of death. |
id |
INCA-1_e1af721fd8977dfaa97d1eef4316eb28 |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/841 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCAFiltro de Vena Cava Inferior: Características Clínicas y Prognósticas de Pacientes com Câncer em INCAFiltro de Veia Cava Inferior: Características Clínicas e Prognósticas de Pacientes Oncológicos do INCAFiltros de Veia Cava/efeitos adversosNeoplasiasTromboembolia VenosaAnálise de SobrevidaMorteVena Cava Filters/adverse effectsNeoplasmsVenous ThromboembolismSurvival AnalysisDeathFiltros de Vena Cava/efectos adversosNeoplasiasTromboembolia VenosaAnálisis de SupervivenciaMuerteIntroduction: Venous thromboembolism is a potentially fatal condition and frequent in oncologic patients. Quite often full anticoagulation is unfeasible, and placement of an inferior vena cava (IVC) filter becomes an option. Clinical indication, however, is controversial and expensive. Objective: To describe the demographic, clinical and epidemiological characteristics of oncologic patients submitted to IVC filter placement and their impact on global survival. Method: Retrospective cohort study with patients undergoing cancer treatment at INCA submitted to IVC filter placement from January 2015 to April 2017. Time between cancer diagnoses and death from any cause was considered for the analysis of the global 5-years survival. Descriptive analysis, survival estimates (Kaplan-Meyer) and Cox regression were performed. Results: 74 patients with a mean age of 54 (+15) years were included. Most of them had gynecological (52.7%) and digestive (20.3%) tumors. The median time between cancer diagnosis and IVC filter placement was 3.48 months (0-203). In the follow-up, 40 deaths (54.1%) were observed with a median time of 25 months (95% CI; 1.76 to 47.32). In the adjusted analysis, 5.63 times greater risk of death was verified in patients with IVC filter placement within six months after cancer diagnosis (HR=4.99; 95% CI; 2.20-11.33; p<0.001), and 2.47 times greater risk among those who did not do it at pre-operation (HR=2.47; 95% CI; 1.08-5.66; p=0.032). Conclusion: IVC filter placement was performed more frequently in patients with gynecological tumors and in until six months after cancer diagnosis was associated with increased risk of death.Introducción: El tromboembolismo venoso es una afección potencialmente mortal y frecuente en pacientes con cáncer. La anticoagulación a menudo no es factible, y la colocación de un filtro de vena cava (FVC) se convierte en una opción. Sin embargo, las indicaciones clínicas son controvertidas y generan un alto costo. Objetivo: Describir las características demográficas, clínicas y epidemiológicas de los pacientes con colocación de CVF y su impacto en la supervivencia general. Método: Estudio de cohorte retrospectivo de pacientes sometidos a tratamiento contra el cáncer en INCA a quienes se les implantó FVC entre enero de 2015 y abril de 2017. En el análisis de la supervivencia general a cinco años, el tiempo transcurrido entre el diagnóstico de cáncer y la muerte cualquier causa Se realizó un análisis descriptivo, estimaciones de supervivencia (Kaplan-Meier) y regresión de Cox. Resultados: Se incluyeron 74 pacientes con una edad media de 54 (+-15) años. La mayoría de ellos tenían tumores ginecológicos (52,7%) y digestivos (20,3%). La mediana del tiempo entre el diagnóstico de cáncer y la colocación de FVC fue de 3,48 meses (0-203). En el período de seguimiento, se observaron 40 muertes (54,1%) con una mediana de tiempo de 25 meses (IC 95%: 1,76 a 47,32). En el análisis ajustado, se observó un riesgo de muerte 5,63 veces mayor en pacientes con colocación de FVC dentro de los seis meses posteriores al diagnóstico de cáncer (HR=4,99; IC 95%: 2,20-11,33; p<0,001) y 2,47 veces mayor riesgo entre aquellos que no lo hicieron antes de la operación (HR=2,47; IC 95%; 1,08-5,66; p=0,032). Conclusión: La colocación de FVC se realizó con mayor frecuencia en pacientes con tumores ginecológicos. La colocación de FVC dentro de los seis meses posteriores al diagnóstico de cáncer se asoció con un mayor riesgo de muerte.Introdução: O tromboembolismo venoso é uma condição potencialmente fatal e frequente no paciente oncológico. Muitas vezes, a anticoagulação é inviável, e a colocação do filtro de veia cava (FVC) torna-se uma opção. A indicação clínica, entretanto, é controversa e gera alto custo. Objetivo: Descrever as características demográficas, clínicas e epidemiológicas dos pacientes com colocação de FVC e seu impacto na sobrevida global. Método: Estudo de coorte retrospectiva com pacientes em tratamento oncológico no INCA, que tiveram FVC implantado de janeiro/2015 até abril/2017. Na análise de sobrevida global em cinco anos, foram considerados o tempo entre o diagnóstico de câncer e o óbito por qualquer causa. Realizaram-se análise descritiva, estimativas de sobrevida (Kaplan-Meier) e regressão de Cox. Resultados: Foram incluídos 74 pacientes com média de idade 54 (+-15) anos. Em sua maioria, apresentavam tumores ginecológicos (52,7%) e digestivos (20,3%). O tempo mediano entre o diagnóstico de câncer e a colocação do FVC foi de 3,48 meses (0-203). No seguimento, foram observados 40 óbitos (54,1%) com mediana de tempo de 25 meses (IC 95%; 1,76-47,32). Na análise ajustada, verificou-se risco 5,63 vezes maior de morrer nos pacientes com colocação do FVC em até seis meses após o diagnóstico de câncer (HR=4,99; IC 95%; 2,20-11,33; p<0,001), e risco 2,47 vezes maior entre aqueles que não fizeram no pré-operatório (HR=2,47; IC 95%; 1,08-5,66; p=0,032). Conclusão: A colocação do FVC foi realizada com maior frequência em pacientes com tumores ginecológicos e em até seis meses após o diagnóstico de câncer foi associada a maior risco de óbito.INCA2020-12-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/84110.32635/2176-9745.RBC.2021v67n1.841Revista Brasileira de Cancerologia; Vol. 67 No. 1 (2021): Jan./Feb./Mar.; e-01841Revista Brasileira de Cancerologia; Vol. 67 Núm. 1 (2021): ene./feb./mar.; e-01841Revista Brasileira de Cancerologia; v. 67 n. 1 (2021): jan./fev./mar.; e-018412176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/841/807https://rbc.inca.gov.br/index.php/revista/article/view/841/1058Copyright (c) 2020 Revista Brasileira de Cancerologiainfo:eu-repo/semantics/openAccessRenni, Marcos Jose PereiraBergmann, AnkeMelo, Andreia Cristina de2021-11-29T18:29:30Zoai:rbc.inca.gov.br:article/841Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T18:29:30Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA Filtro de Vena Cava Inferior: Características Clínicas y Prognósticas de Pacientes com Câncer em INCA Filtro de Veia Cava Inferior: Características Clínicas e Prognósticas de Pacientes Oncológicos do INCA |
title |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
spellingShingle |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA Renni, Marcos Jose Pereira Filtros de Veia Cava/efeitos adversos Neoplasias Tromboembolia Venosa Análise de Sobrevida Morte Vena Cava Filters/adverse effects Neoplasms Venous Thromboembolism Survival Analysis Death Filtros de Vena Cava/efectos adversos Neoplasias Tromboembolia Venosa Análisis de Supervivencia Muerte |
title_short |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
title_full |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
title_fullStr |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
title_full_unstemmed |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
title_sort |
Placement of Inferior Vena Cava Filter: Clinical and Prognostic Characteristics of Cancer Patients at INCA |
author |
Renni, Marcos Jose Pereira |
author_facet |
Renni, Marcos Jose Pereira Bergmann, Anke Melo, Andreia Cristina de |
author_role |
author |
author2 |
Bergmann, Anke Melo, Andreia Cristina de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Renni, Marcos Jose Pereira Bergmann, Anke Melo, Andreia Cristina de |
dc.subject.por.fl_str_mv |
Filtros de Veia Cava/efeitos adversos Neoplasias Tromboembolia Venosa Análise de Sobrevida Morte Vena Cava Filters/adverse effects Neoplasms Venous Thromboembolism Survival Analysis Death Filtros de Vena Cava/efectos adversos Neoplasias Tromboembolia Venosa Análisis de Supervivencia Muerte |
topic |
Filtros de Veia Cava/efeitos adversos Neoplasias Tromboembolia Venosa Análise de Sobrevida Morte Vena Cava Filters/adverse effects Neoplasms Venous Thromboembolism Survival Analysis Death Filtros de Vena Cava/efectos adversos Neoplasias Tromboembolia Venosa Análisis de Supervivencia Muerte |
description |
Introduction: Venous thromboembolism is a potentially fatal condition and frequent in oncologic patients. Quite often full anticoagulation is unfeasible, and placement of an inferior vena cava (IVC) filter becomes an option. Clinical indication, however, is controversial and expensive. Objective: To describe the demographic, clinical and epidemiological characteristics of oncologic patients submitted to IVC filter placement and their impact on global survival. Method: Retrospective cohort study with patients undergoing cancer treatment at INCA submitted to IVC filter placement from January 2015 to April 2017. Time between cancer diagnoses and death from any cause was considered for the analysis of the global 5-years survival. Descriptive analysis, survival estimates (Kaplan-Meyer) and Cox regression were performed. Results: 74 patients with a mean age of 54 (+15) years were included. Most of them had gynecological (52.7%) and digestive (20.3%) tumors. The median time between cancer diagnosis and IVC filter placement was 3.48 months (0-203). In the follow-up, 40 deaths (54.1%) were observed with a median time of 25 months (95% CI; 1.76 to 47.32). In the adjusted analysis, 5.63 times greater risk of death was verified in patients with IVC filter placement within six months after cancer diagnosis (HR=4.99; 95% CI; 2.20-11.33; p<0.001), and 2.47 times greater risk among those who did not do it at pre-operation (HR=2.47; 95% CI; 1.08-5.66; p=0.032). Conclusion: IVC filter placement was performed more frequently in patients with gynecological tumors and in until six months after cancer diagnosis was associated with increased risk of death. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-28 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/841 10.32635/2176-9745.RBC.2021v67n1.841 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/841 |
identifier_str_mv |
10.32635/2176-9745.RBC.2021v67n1.841 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/841/807 https://rbc.inca.gov.br/index.php/revista/article/view/841/1058 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Brasileira de Cancerologia info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Revista Brasileira de Cancerologia |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 67 No. 1 (2021): Jan./Feb./Mar.; e-01841 Revista Brasileira de Cancerologia; Vol. 67 Núm. 1 (2021): ene./feb./mar.; e-01841 Revista Brasileira de Cancerologia; v. 67 n. 1 (2021): jan./fev./mar.; e-01841 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042245445091328 |